Global study links COVID-19 vaccines with heart, brain disorders

The COVID-19 vaccines that emerged as a beacon of hope in the fight against the deadly…

Positive data from Phase II to III study of Covaxin in the US: Ocugene

Symbolic picture only. maker of covaccine Bharat Biotech’US partner Ocugen Inc said on January 9 that…

New mRNA vaccines may reduce risk of malaria infection: study

Two new mRNA vaccines have been developed that can markedly reduce both malaria infection and transmission.…

Can we ‘boost’ our way out of the COVID-19 pandemic for the long term?

The mRNA vaccines currently used against COVID-19 in the US have been highly successful in preventing…

US health regulators consider approving second COVID-19 booster shot: report

US health regulator A. are considering authorizing a possible fourth dose of covid-19 vaccine in decline,…

Morning Digest | Polling for the first phase in Uttar Pradesh begins today; Three-judge bench of Karnataka High Court to hear hijab petitions, and more

A select list of stories to read before starting your day. The high-stakes electoral battle in…

The case for vaccinating children against COVID-19

Protecting all children, especially those with risk factors, should be a humanitarian priority for the government…

Look beyond mRNA vaccines to maximize global coverage

At the start of the pandemic, many of us hoped that India would help vaccinate the…

Coronavirus Live Updates | Kovid negative report necessary in Ganga Sagar fair: Calcutta HC

India’s COVID-19 vaccination coverage crossed 153.7 crore on Tuesday, with 76,68,282 vaccine doses given till 7…

The waiting game in the year of results

In the wonderful movie of Charlie Chaplin modern times, The defining image of modernity is the…